Midazolam ameliorates the behavior deficits of a rat posttraumatic stress disorder model through dual 18 kDa translocator protein and central benzodiazepine receptor and neurosteroidogenesis

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Miao, Yu Liang ^a   Guo, Wen Zhi ^b   Shi, Wen Zhu ^c   Fang, Wei Wu ^a   Liu, Yan ^a   Liu, Ji ^a   Li, Bao Wei ^a   Wu, Wei ^a   Li, Yun Feng ^d  

^a 306 HOSPITAL OF PLA   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Hainan Branch of General Hospital of PLA   (China)

^d BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; FINASTERIDE; FLUMAZENIL; MIDAZOLAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; SERTRALINE; 4 AMINOBUTYRIC ACID A RECEPTOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BZRP PROTEIN, RAT; CARRIER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CATALEPSY; CONTEXTUAL FEAR PARADIGM; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ELEVATED PLUS MAZE TEST; EXPERIMENTAL ANXIETY TEST; LOCOMOTION; MALE; NEUROSTEROIDOGENESIS; NONHUMAN; OPEN FIELD TEST; POSTTRAUMATIC STRESS DISORDER; RAT; REPEATED DRUG DOSE; STEROIDOGENESIS; TRANQUILIZING ACTIVITY; ANIMAL; DISEASE MODEL; DRUG EFFECTS; FEAR; MAZE TEST; METABOLISM; SPRAGUE DAWLEY RAT; STRESS DISORDERS, POST-TRAUMATIC;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FEAR; MALE; MAZE LEARNING; MIDAZOLAM; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SERTRALINE; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84903780264     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101450     Document Type: Article

References (51)

1. Akk G, Shu HJ, Wang C, Steinbach JH, Zorumski CF, et al. (2005) Neurosteroid access to the GABAA receptor. J Neurosci 25: 11605-11613.
2. Leskin LP, White PM (2007) Attentional networks reveal executive function deficits in posttraumatic stress disorder. Neuropsychology 21: 275-284. (Pubitemid 46725817)
3. Hopper JW, Frewen PA, van der Kolk BA, Lanius RA (2007) Neural correlates of reexperiencing, avoidance, and dissociation in PTSD: symptom dimensions and emotion dysregulation in responses to script-driven trauma imagery. J Trauma Stress 20: 713-725. (Pubitemid 350144879)
4. Chang FC, Opp MR (2001) Corticotropin-releasing hormone (CRH) as a regulator of waking. Neurosci Biobehav Rev 25: 445-453.
5. Gabr RW, Birkle DL, Azzaro AJ (1995) Stimulation of the amygdala by glutamate facilitates corticotropin-releasing factor release from the median eminence and activation of the hypothalamic-pituitary-adrenal axis in stressed rats. Neuroendocrinology 62: 333-339.
6. Debiec J, Ledoux JE (2004) Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala. Neuroscience 129: 267-272. (Pubitemid 39388847)
7. Davidson JR, Weisler RH, Malik ML, Connor KM (1998) Treatment of posttraumatic stress disorder with nefazodone. Int Clin Psychopharmacol 13: 111-113. (Pubitemid 28318349)
8. Szabo ST, de Montigny C, Blier P (1999) Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers. Br J Pharmacol 126: 568-571. (Pubitemid 29087832)
9. Yamada J, Saitow F, Satake S, Kiyohara T, Konishi S (1999) GABA(B) receptor-mediated presynaptic inhibition of glutamatergic and GABAergic transmission in the basolateral amygdala. Neuropharmacology 38: 1743-1753. (Pubitemid 29430249)
10. Brady KT, Clary CM (2003) Affective and anxiety comorbidity in posttraumatic stress disorder treatment trials of sertraline. Compr Psychiatry 44: 360-369. (Pubitemid 37151811)
11. Ravindran LN, Stein MB (2009) Pharmacotherapy of PTSD: premises, principles, and priorities. Brain Res 1293: 24-39.
12. Nothdurfter C, Rammes G, Baghai TC, Schule C, Schumacher M, et al. (2012) Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile. J Neuroendocrinol 24: 82-92.
13. Maeda J, Higuchi M, Inaji M, Ji B, Haneda E, et al. (2007) Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res 1157: 100-111. (Pubitemid 46935074)
14. Dell'Osso L, Da Pozzo E, Carmassi C, Trincavelli ML, Ciapparelli A, et al. (2010) Lifetime manic-hypomanic symptoms in post-traumatic stress disorder: relationship with the 18 kDa mitochondrial translocator protein density. Psychiatry Res 177: 139-143.
15. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, et al. (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27: 402-409. (Pubitemid 44069585)
16. Costa B, Da Pozzo E, Martini C (2012) Translocator protein as a promising target for novel anxiolytics. Curr Top Med Chem 12: 270-285.
17. Qiu ZK, Zhang LM, Zhao N, Chen HX, Zhang YZ, et al. (2013) Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 45: 40-46.
18. Senses E, Apan A, Kose EA, Oz G, Rezaki H (2013) The effects of midazolam and dexmedetomidine infusion on peri-operative anxiety in regional anesthesia. Middle East J Anesthesiol 22: 35-40.
19. Treggiari-Venzi M, Borgeat A, Fuchs-Buder T, Gachoud JP, Suter PM (1996) Overnight sedation with midazolam or propofol in the ICU: effects on sleep quality, anxiety and depression. Intensive Care Med 22: 1186-1190. (Pubitemid 26405507)
20. Armario A, Escorihuela RM, Nadal R (2008) Long-term neuroendocrine and behavioural effects of a single exposure to stress in adult animals. Neurosci Biobehav Rev 32: 1121-1135.
21. Takahashi T, Morinobu S, Iwamoto Y, Yamawaki S (2006) Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats. Psychopharmacology (Berl) 189: 165-173. (Pubitemid 44691539)
22. Khan S, Liberzon I (2004) Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD. Psychopharmacology (Berl) 172: 225-229. (Pubitemid 38388773)
23. Zhang LM, Yao JZ, Li Y, Li K, Chen HX, et al. (2012) Anxiolytic effects of flavonoids in animal models of posttraumatic stress disorder. Evid Based Complement Alternat Med 2012: 623753.
24. Kita A, Kohayakawa H, Kinoshita T, Ochi Y, Nakamichi K, et al. (2004) Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. Br J Pharmacol 142: 1059-1072. (Pubitemid 39093001)
25. Tokuda K, O'Dell KA, Izumi Y, Zorumski CF (2010) Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis. J Neurosci 30: 16788-16795.
26. Kita A, Furukawa K (2008) Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice. Pharmacol Biochem Behav 89: 171-178.
27. Paez-Martinez N, Aldrete-Audiffred J, Gallardo-Tenorio A, Castro-Garcia M, Estrada-Camarena E, et al. (2013) Participation of GABAA, GABA(B) receptors and neurosteroids in toluene-induced hypothermia: evidence of concentration-dependent differences in the mechanism of action. Eur J Pharmacol 698: 178-185.
28. Brot MD, Akwa Y, Purdy RH, Koob GF, Britton KT (1997) The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol 325: 1-7. (Pubitemid 27190448)
29. Liberzon I, Krstov M, Young EA (1997) Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology 22: 443-453. (Pubitemid 27431506)
30. Suenaga T, Morinobu S, Kawano K, Sawada T, Yamawaki S (2004) Influence of immobilization stress on the levels of CaMKII and phospho-CaMKII in the rat hippocampus. Int J Neuropsychopharmacol 7: 299-309. (Pubitemid 39166464)
31. Bai M, Zhu X, Zhang Y, Zhang S, Zhang L, et al. (2012) Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PLoS One 7: e46921.
32. Xue R, Jin ZL, Chen HX, Yuan L, He XH, et al. (2013) Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor. Eur Neuropsychopharmacol 23: 728-741.
33. Maier SF (1990) Role of fear in mediating shuttle escape learning deficit produced by inescapable shock. J Exp Psychol Anim Behav Process 16: 137-149.
34. Fanselow MS (1980) Conditioned and unconditional components of post-shock freezing. Pavlov J Biol Sci 15: 177-182.
35. Anagnostaras SG, Wood SC, Shuman T, Cai DJ, Leduc AD, et al. (2010) Automated assessment of pavlovian conditioned freezing and shock reactivity in mice using the video freeze system. Front Behav Neurosci 4.
36. Li S, Murakami Y, Wang M, Maeda K, Matsumoto K (2006) The effects of chronic valproate and diazepam in a mouse model of posttraumatic stress disorder. Pharmacol Biochem Behav 85: 324-331. (Pubitemid 44889260)
37. Wang HN, Peng Y, Tan QR, Wang HH, Chen YC, et al. (2009) Free and Easy Wanderer Plus (FEWP), a polyherbal preparation, ameliorates PTSD-like behavior and cognitive impairments in stressed rats. Prog Neuropsychopharmacol Biol Psychiatry 33: 1458-1463.
38. Imanaka A, Morinobu S, Toki S, Yamawaki S (2006) Importance of early environment in the development of post-traumatic stress disorder-like behaviors. Behav Brain Res 173: 129-137. (Pubitemid 44604265)
39. Cao J, Shi X, Miao X, Xu J (2009) Effects of premedication of midazolam or clonidine on perioperative anxiety and pain in children. Biosci Trends 3: 115-118.
40. Kain ZN, MacLaren J, McClain BC, Saadat H, Wang SM, et al. (2007) Effects of age and emotionality on the effectiveness of midazolam administered preoperatively to children. Anesthesiology 107: 545-552. (Pubitemid 47480559)
41. Rupprecht R, Rammes G, Eser D, Baghai TC, Schule C, et al. (2009) Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325: 490-493.
42. Kita A, Kinoshita T, Kohayakawa H, Furukawa K, Akaike A (2009) Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand. Prog Neuropsychopharmacol Biol Psychiatry 33: 1040-1045.
43. Lambert JJ, Cooper MA, Simmons RD, Weir CJ, Belelli D (2009) Neurosteroids: endogenous allosteric modulators of GABA(A) receptors. Psychoneuroendocrinology 34 Suppl 1: S48-58.
44. Belelli D, Lambert JJ (2005) Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 6: 565-575. (Pubitemid 40942823)
45. Pinna G, Costa E, Guidotti A (2009) SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol 9: 24-30.
46. Pibiri F, Nelson M, Guidotti A, Costa E, Pinna G (2008) Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder. Proc Natl Acad Sci U S A 105: 5567-5572. (Pubitemid 351753903)
47. Rasmusson AM, Pinna G, Paliwal P, Weisman D, Gottschalk C, et al. (2006) Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol Psychiatry 60: 704-713. (Pubitemid 44427765)
48. Rosenkranz JA, Moore H, Grace AA (2003) The prefrontal cortex regulates lateral amygdala neuronal plasticity and responses to previously conditioned stimuli. J Neurosci 23: 11054-11064. (Pubitemid 37548939)
49. Guidotti A, Dong E, Matsumoto K, Pinna G, Rasmusson AM, et al. (2001) The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders. Brain Res Brain Res Rev 37: 110-115. (Pubitemid 34020725)
50. Hosie AM, Wilkins ME, da Silva HM, Smart TG (2006) Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444: 486-489. (Pubitemid 44809065)
51. Lambert JJ, Belelli D, Hill-Venning C, Peters JA (1995) Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 16: 295-303.